University College London

TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D

Retrieved on: 
Monday, December 18, 2023
Technology transfer, Economics, Bachelor, IND, PLC, Research, Process, TC, Holding, Doctor of Philosophy, Eye, Cancer, TCB, MHC, GMP, University, Type 1 diabetes, University College London, Research fellow, King's College London, CD19, UCL, Generation, Pharmaceutical industry

Additionally, TC BioPharm's Commercial Development Division will explore new opportunities with third parties to monetize the company's production capabilities using the GMP licensed facility.

Key Points: 
  • Additionally, TC BioPharm's Commercial Development Division will explore new opportunities with third parties to monetize the company's production capabilities using the GMP licensed facility.
  • Prior to serving as TC BioPharm's Head of Process Development, Dr. Bor completed a Bsc Hons degree in Immunology from the University of Glasgow.
  • Lauren Joined TC BioPharm in 2019, and her area of research has been the process development and technology transfer of TC BioPharm's Unmodified cryopreserved Vγ9Vδ2 T cell manufacturing process.
  • "TC BioPharm understands that early-stage biotech companies have different needs and expectations than that of large pharmaceutical companies.

Autolus Therapeutics to Host Analyst / Investor event at the American Society of Hematology (ASH) Annual Meeting 2023

Retrieved on: 
Wednesday, November 15, 2023
Webcast, Associate, Cancer Institute, Therapy, ASH, Poster, Research, University College London, UCLH, UCL, Detail, Doctor of Philosophy, Royal College of Pathologists, Flour, Pharmaceutical industry, Management, MD

Time: The presentation will be from 8:00 AM PT / 4:00 PM GMT to 9:00 AM PT / 5:00 PM GMT.

Key Points: 
  • Time: The presentation will be from 8:00 AM PT / 4:00 PM GMT to 9:00 AM PT / 5:00 PM GMT.
  • Onsite access to the event available from 7:45am PT
    Speakers: Dr. Claire Roddie, MD, PhD, FRCPath, Associate Professor Haematology and Honorary Consultant Haematologist, Cancer Institute, University College London (UCL); Dr. Christian Itin, Chief Executive Officer, Autolus.
  • Webcast Registration: A live webcast will be held alongside the event.
  • A recording of the event together with the presentation materials will be available on the Company’s website after the event.

Certa Therapeutics presents positive data from a Phase 2 clinical study highlighting the potential benefit of FT011 as a novel treatment for scleroderma

Retrieved on: 
Wednesday, November 15, 2023
Safety, Therapy, Treatment, University, Aes, Scleroderma, Clutch (eggs), Disease, Clinical trial, Biotechnology, EMA, Patient, Royal Free Hospital, FDA, American College of Rheumatology, American College, University College London, RSS, Transcriptomics technologies, MD, Quality of life, ACR, Inflammation, Fibrosis, Pharmaceutical industry, Atlit, Rheumatology

The study safety profile demonstrated that FT011 was safe and well tolerated, with no differences in adverse event (AE) rates between the treatment arms.

Key Points: 
  • The study safety profile demonstrated that FT011 was safe and well tolerated, with no differences in adverse event (AE) rates between the treatment arms.
  • There were no serious AEs reported in the study, nor any AEs resulting in study drug interruption, withdrawal or discontinuation.
  • This suggests that FT011 may have a positive effect for scleroderma patients by reducing the inflammation and fibrosis associated with the disease.
  • It is important to advance safe and effective treatments through clinical development, given the limited therapeutic options for scleroderma patients.

Camena Bioscience Appoints Dr Nicola Thompson as Chair of the Board

Retrieved on: 
Wednesday, December 6, 2023
Science, Biotechnology, Research, Pharmaceutical, Environment, Health, Genetics, Green Technology, Acquisition, Cell biology, DNA, Therapy, Gene, Chair, Chairperson, Astellas Pharma, University College London, GSK, Roche, Growth, Doctor of Philosophy, Pharma, Pharmaceutical industry, Amphisbaena, Camena

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors.

Key Points: 
  • Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors.
  • Dr Steve Harvey, CEO, Camena Bioscience commented: "Nicola is a successful CEO and Chair and a fantastic addition to the Board.
  • Camena Bioscience enables researchers to ‘write’ DNA with the same confidence and ease with which we can ‘read’ DNA.
  • Dr Nicola Thompson, Chair of the Board, Camena Bioscience, added: “I am delighted to join the Company as its Chair at this pivotal stage of growth.

Homrich Berg Adds Depth to HB Family Office Team with New Principal and Director

Retrieved on: 
Monday, December 4, 2023
Personal Finance, Finance, Consulting, Banking, Professional Services, Atlanta Speech School, Chairperson, Accounting, Life, Multimedia, Equity, Boston University, University College London, Business administration, MBA, University, History, Diversity, Councillor, Business, Face, Rotary International, American Jews, Financial services, Management, Economics

Homrich Berg is excited to welcome Billy Levine as a Principal, enhancing the $14 billion, Atlanta-based RIA’s HB Family Office capabilities for serving ultra-high-net-worth clients.

Key Points: 
  • Homrich Berg is excited to welcome Billy Levine as a Principal, enhancing the $14 billion, Atlanta-based RIA’s HB Family Office capabilities for serving ultra-high-net-worth clients.
  • This comes after the recent addition of Alex Arnold joining the firm as a Director within the HB Family Office in November.
  • View the full release here: https://www.businesswire.com/news/home/20231204422003/en/
    Principal Billy Levine and Director Alex Arnold (Photo: Business Wire)
    Levine brings to Homrich Berg more than 25 years of experience in the financial services industry.
  • “We are also pleased to add Alex, who brings a fresh perspective and adds to our already deep bench of HB Family Office advisors.

COP28 Highlight: NaaS held "Enterprise-Association-Academy-Research" Hybrid Forum for Seeking Opportunity of China-UAE Cooperation in New Energy

Retrieved on: 
Thursday, December 14, 2023
Carbon, Belt, Classification, 21st Century Business Herald, O&M, New energy, Wave, Policy, Yoy, COP28, Lawrence Berkeley National Laboratory, EVS, Recycling, Peking University, Conference of the Parties, Collection, ICE, Infrastructure, Climate change, Algorithm, Wind, RMB, EPR, University College London, Institute for Energy Efficiency, Network as a service, University, Conference, Philosophy, DRF, UNFCCC, Electricity, Multilateralism, EV, Government, AI, Failure, PV, EPC, ESG, Renewable energy, Cryptocurrency

The forum is intended to make China's new energy practice cases known in the world and tap into space and potential in the future of new energy.

Key Points: 
  • The forum is intended to make China's new energy practice cases known in the world and tap into space and potential in the future of new energy.
  • Wang Xiangyi, Secretary-General of CANGO and Yang Fuqiang, Distinguished Research Fellow (DRF) of Institute of Energy, Peking University graced and addressed the forum.
  • Mr. Zhai defined transport as a crucial area of carbon emissions, accounting for 1/4 of the world's total carbon emissions.
  • During COP28, Chinese firms engaged in energy digitization, typified by NaaS, provided reference and experience in promoting green reform and sustainability pattern.

British Council Pioneering Climate Initiatives through Arts, Culture, and Education at COP28 in Dubai

Retrieved on: 
Thursday, December 7, 2023
Islam, Research, Climate change, Education, Better Late Than Never, COP28, Climate, Risk, Publication, Culture, Science, Council, University College London, UCL, Conference, University, Partnership, British Council, COP, Tourism, Nursing, Ink, MENA

At COP28, the British Council is highlighting its commitment to climate action through various impactful initiatives.

Key Points: 
  • At COP28, the British Council is highlighting its commitment to climate action through various impactful initiatives.
  • Aida Salamanca, Country Director (UAE) of the British Council, said, "In hosting COP28, the UAE provides a unique platform for global climate discussions.
  • - This research emphasises the importance of international collaboration in climate education and focuses on addressing climate, environmental, and biodiversity crises through girls' education.
  • Engagement and Advocacy in Climate Education: Working on initiatives to integrate climate change education into school curriculums and teacher training programs.

British Council Pioneering Climate Initiatives through Arts, Culture, and Education at COP28 in Dubai

Retrieved on: 
Thursday, December 7, 2023
Islam, Research, Climate change, Education, Better Late Than Never, COP28, Climate, Risk, Publication, Culture, Science, Council, University College London, UCL, Conference, University, Partnership, British Council, COP, Tourism, Nursing, Ink, MENA

At COP28, the British Council is highlighting its commitment to climate action through various impactful initiatives.

Key Points: 
  • At COP28, the British Council is highlighting its commitment to climate action through various impactful initiatives.
  • Aida Salamanca, Country Director (UAE) of the British Council, said, "In hosting COP28, the UAE provides a unique platform for global climate discussions.
  • - This research emphasises the importance of international collaboration in climate education and focuses on addressing climate, environmental, and biodiversity crises through girls' education.
  • Engagement and Advocacy in Climate Education: Working on initiatives to integrate climate change education into school curriculums and teacher training programs.

Citycon announces Chief Financial Officer transition

Retrieved on: 
Friday, December 1, 2023
CFO, University college, University College London, Master of Science, Friends, Investment banking, Family, News, Economics, Corporate finance, SEB, Human, Pleasure, Management, Citycon

HELSINKI, Dec. 1, 2023 /PRNewswire/ -- Citycon has announced an orderly transition of its Chief Financial Officer position to take place in early 2024. Bret D. McLeod, current Chief Financial Officer of Citycon, has announced his intention to resign from his position effective January 31, 2024, to pursue another opportunity back in his native United States.At the same time, the Board of Directors of Citycon has unanimously appointed Sakari Järvelä, current VP, Corporate Finance and Investor Relations, to the position of CFO-elect, beginning immediately.  Mr. Järvelä will assume the CFO role and will become a member of Citycon's Corporate Management Committee on February 1, 2024 and continue to work side-by-side with Mr. McLeod until that date. Prior to joining Citycon in 2022, Mr. Järvelä spent the majority of his career in various European investment banking roles, the most recent at SEB as the Head of Investment Banking in Germany and holds an MSc Economics from University College London.  He resides in Helsinki metropolitan area with his wife and son."It is with mixed emotions that I leave Citycon.  These past three years have been an incredible experience for myself, and my family, and I am excited for what lies ahead for us as we move back to the U.S.," says Bret McLeod, Chief Financial Officer of Citycon. "At the same time, I am very proud of the numerous achievements and transactions we have completed and sad to leave wonderful colleagues and friends. The great news is that I could not leave the position in better hands than that of my successor, Sakari Järvelä.  Sakari has worked closely with me during my tenure and has been involved in every financial and strategic aspect of the company, while representing the company as a trusted voice to the investment community.  I wish him, and Citycon, nothing but great success and am happy to assist anyway I can during this transition." "While we are sad to see Bret leave, we want to thank him for his many contributions to Citycon and are appreciative to him for ensuring a smooth transition.  He has been a great partner to me and the Board and we wish him, and his family, well as he pursues a great opportunity back home in the U.S," says F. Scott Ball, Chief Executive Officer of Citycon. "That said, I am thrilled to welcome Sakari to the leadership team at Citycon and congratulate him on his future appointment as CFO.  Sakari is a dedicated and talented executive whom I have had the pleasure of working with on a variety of complicated transactions during his time at Citycon.  I have also witnessed the respect he garners from our employees, banking partners, investors, and rating agencies and know that his elevation to CFO will be seamless.""I am humbled and honoured by the Board's decision to nominate me as CFO-elect and to serve as the next Chief Financial Officer of Citycon," says Sakari Järvelä, CFO-elect of Citycon.  "It has been a pleasure to work with Bret and I am grateful for his mentorship and friendship and his assistance in making this transition an efficient one.  I am excited to join a leadership team I have great respect for and to continue to execute on Citycon's commitment to maintaining the highest financial standards and our investment grade rating. "

Key Points: 
  • HELSINKI, Dec. 1, 2023 /PRNewswire/ -- Citycon has announced an orderly transition of its Chief Financial Officer position to take place in early 2024.
  • Bret D. McLeod, current Chief Financial Officer of Citycon, has announced his intention to resign from his position effective January 31, 2024, to pursue another opportunity back in his native United States.
  • These past three years have been an incredible experience for myself, and my family, and I am excited for what lies ahead for us as we move back to the U.S.," says Bret McLeod, Chief Financial Officer of Citycon.
  • "I am humbled and honoured by the Board's decision to nominate me as CFO-elect and to serve as the next Chief Financial Officer of Citycon," says Sakari Järvelä, CFO-elect of Citycon.

Hyundai Motor Company and University College London to Collaborate on Carbon-Free Future Technologies

Retrieved on: 
Wednesday, November 22, 2023
Hydrogen, Mansion House, Carbon, International trade, Nobel Prize, Multimedia, Hyundai Motor Company, Hydrogen production, University College London, Engine, UCL, Provost, Partnership, Development, Graduate Business Forum, Paris Agreement, Temperature, Hyundai, MOU, Automotive industry, Research

Hyundai Motor and UCL to conduct joint research on hydrogen production, fuel cells and electrification technologies, leveraging UCL's new Advanced Propulsion Lab

Key Points: 
  • Hyundai Motor and UCL to conduct joint research on hydrogen production, fuel cells and electrification technologies, leveraging UCL's new Advanced Propulsion Lab
    SEOUL, South Korea, Nov. 22, 2023 /PRNewswire/ -- Hyundai Motor Company today announced that it is partnering with the world-renowned University College London (UCL) to jointly research carbon-neutral future technologies.
  • Hyundai Motor signed a memorandum of understanding (MOU) on 'Cooperation in areas of Research and Development for Hydrogen Production, Hydrogen Fuel Cells and Electrification Technology' with UCL at Mansion House in London on November 22.
  • With both South Korea and UK aiming to achieve carbon neutrality by 2050, Hyundai Motor looks to accelerate the development of a hydrogen economy and realize a sustainable future mobility ecosystem through this MOU.
  • UCL is a prestigious research-oriented university that is consistently ranked at the top of global university rankings and has produced dozens of Nobel Prize and Fields Medal winners.